Browse > Article
http://dx.doi.org/10.3345/kjp.2010.53.8.786

Disease-specific pluripotent stem cells  

Kang, Hoon-Chul (Department of Pediatrics, Pediatric Epilepsy Clinics, Severance Children's Hospital, Epilepsy Research Institute, Yonsei University College of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.53, no.8, 2010 , pp. 786-789 More about this Journal
Abstract
Induced pluripotent stem (iPS) cells are generated by epigenetic reprogramming of somatic cells through the exogenous expression of transcription factors. Recently, the generation of iPS cells from patients with a variety of genetic diseases was found to likely have a major impact on regenerative medicine, because these cells self-renew indefinitely in culture while retaining the capacity to differentiate into any cell type in the body, thereby enabling disease investigation and drug development. This review focuses on the current state of iPS cell technology and discusses the potential applications of these cells for disease modeling; drug discovery; and eventually, cell replacement therapy.
Keywords
Induced pluripotent stem cells; Transcription factors;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76.   DOI   ScienceOn
2 Eminli S, Foudi A, Stadtfeld M, Maherali N, Ahfeldt T, Mostoslavsky G, et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 2009;41:968-76.   DOI   ScienceOn
3 Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008;454:49-55.   DOI   ScienceOn
4 Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, Ding S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 2008;3:568-74.   DOI   ScienceOn
5 Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324:797-801.   DOI   ScienceOn
6 Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, et al. Disease-specific induced pluripotent stem cells. Cell 2008;134:877-86.   DOI   ScienceOn
7 Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008;454:49-55.   DOI   ScienceOn
8 Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008;322:945-9.   DOI   ScienceOn
9 Gonzalez F, Barragan Monasterio M, Tiscornia G, Montserrat Pulido N, Vassena R, et al. Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc Natl Acad Sci 2009;106:8918-22.   DOI   ScienceOn
10 Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009;4:472-6.   DOI   ScienceOn
11 Wernig M, Meissner A, Cassady JP, Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008;2:10-2.   DOI   ScienceOn
12 Blelloch R, Venere M, Yen J, Ramalho-Santos M. Generation of induced pluripotent stem cells in the absence of drug selection. Cell Stem Cell 2007;1: 245-7.   DOI   ScienceOn
13 Wakayama T, Hayashi Y, Ogura A. Participation of the female pronucleus derived from the second polar body in full embryonic development of mice. J Reprod Fertil 1997;110:263-6.   DOI   ScienceOn
14 Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009;136:964-77.   DOI   ScienceOn
15 Cox JL, Rizzino A. Induced pluripotent stem cells: what lies beyond the paradigm shift. Experimental Biology and Medicine 2010;235:148-58.   DOI   ScienceOn
16 Kiskinis E, Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 2010;120:51-9.   DOI   ScienceOn
17 Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008;26:795-7.   DOI   ScienceOn
18 Kirschstein R. The stem cell. In: Kirschstein R, editor. Stem cells: scientific progress and future research directions. 1st ed. Maryland: National Institutes of Health, 2001:1-4.
19 Hochedlinger K, Jaenisch R. Nuclear reprogramming and pluripotency. Nature 2006; 441:1061-7.   DOI   ScienceOn
20 Maherali N, Hochedlinger K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 2008;3:595-605.   DOI   ScienceOn
21 Sell S. Stem cells: What are they? Where do they come from? Why are they here? When do they go wrong? Where are they going? In: Sell S, editor, Stem cells handbook. 1st ed. Totowa: Humana Press Co, 2004:1-18.